Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxicity”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Early research (Phase 1)Study completedNCT01447732
What this trial is testing

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid TumourAdenocarcinoma of the ColorectalAdenocarcinoma of the Pancreas
Kyowa Kirin Co., Ltd. 71
Not applicableUnknownNCT02669186
What this trial is testing

Effects of Anesthetic Technique on NK Cells

Who this might be right for
PainAnesthesiaCancer
Cedars-Sinai Medical Center 20
Not applicableUnknownNCT03906201
What this trial is testing

Effect of Phytoecdysterone Administration in Subjects With Prediabetes

Who this might be right for
PreDiabetes
University of Guadalajara 34
Not applicableStudy completedNCT00565305
What this trial is testing

Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment

Who this might be right for
Breast Cancer
University of Iowa 150
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT02983006
What this trial is testing

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 12
Not applicableActive Not RecruitingNCT05171972
What this trial is testing

Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of Southern California 40
Not applicableUnknownNCT05596149
What this trial is testing

Assessment of the Cytotoxic and Genotoxic Effect of Toothpastes With Different Forms of Fluoride on the Buccal Mucosa

Who this might be right for
DNA Damage
University of Zagreb 80
Not applicableLooking for participantsNCT01087333
What this trial is testing

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Who this might be right for
Hairy Cell Leukemia (HCL)Chronic Lymphocytic Leukemia (CLL)Non-Hodgkins Lymphoma (NHL)+2 more
National Cancer Institute (NCI) 1,263
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Post-approval studies (Phase 4)Active Not RecruitingNCT04083430
What this trial is testing

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination

Who this might be right for
HealthyCytotoxicityYellow Fever Vaccination Reaction
University of Aarhus 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02768363
What this trial is testing

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

Who this might be right for
Prostate Cancer
Candel Therapeutics, Inc. 187
Testing effectiveness (Phase 2)Study completedNCT00001421
What this trial is testing

Methimazole to Treat Polymyositis and Dermatomyositis

Who this might be right for
DermatomyositisPolymyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03571633
What this trial is testing

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

Who this might be right for
HER2-positive Breast CancerOperable Breast Cancer
Centre Leon Berard 90
Early research (Phase 1)Study completedNCT03663998
What this trial is testing

Optimising DNA Vaccinations in Healthy Volunteers

Who this might be right for
HIV-1-infection
Imperial College London 36
Very early researchUnknownNCT03214939
What this trial is testing

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Research Institute of Fundamental and Clinical Immunology 30
Not applicableUnknownNCT02078362
What this trial is testing

ADCC Against Gastric Cancer Cells

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03949283
What this trial is testing

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Who this might be right for
Recurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer
Cordgenics, LLC 150
Not applicableEnded earlyNCT01068470
What this trial is testing

Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy

Who this might be right for
MelanomaKidney Cancer
Loma Linda University 11
Not applicableStudy completedNCT02019628
What this trial is testing

Enhanced Natural Killer Cell Activity and RBAC

Who this might be right for
Family Member
University of Miami 20
Load More Results